로딩 중…
지수 로딩 중…
Abivax S.A.
ABVX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
FR
FR$99.15-1.00%
2026-06-18
Price Chart
Abivax S.A.+1538.84%
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $7.90B |
| Revenue | $0.00 |
| Net Income | $-381M |
| Total Assets | $686M |
| Net Assets | $534M |
| Value | |
| P/B | 14.78x |
| FCF Yield | -2.24% |
| Profitability | |
| ROE | -71.30% |
| ROA | -55.54% |
| Financial Health | |
| Debt Ratio | 28.37% |
| Total Debt | $38M |
| FCF | $-177M |
| Cash | $607M |
| Current Ratio | 8.75x |
| Performance | |
| 1Y Return | 1538.84% |
| 1M Return | -12.82% |
| From 52W High | -33.38% |
| 1Y MDD | -50.11% |
| Trading | |
| Volume | 1,682,621 shares |
| Trading Value | $167M |
| Per Share | |
| EPS | $-7.13 |
| BPS | $7.08 |